Page last updated: 2024-08-18

quinuclidines and Osteosarcoma

quinuclidines has been researched along with Osteosarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lai, J; Li, C; Li, P; Li, Y; Li, Z; Rastogi, S1
Bergman, J; Bykov, VJ; Selivanova, G; Stridh, H; Westman, J; Wiman, KG; Zache, N1

Trials

1 trial(s) available for quinuclidines and Osteosarcoma

ArticleYear
Does a single dose of palonosetron have any role in preventing acute chemotherapy-induced nausea and vomiting in pediatric osteosarcoma patients without dexamethasone? A randomized clinical trial.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2022, Volume: 31, Issue:3

    Topics: Antineoplastic Agents; Child; Dexamethasone; Humans; Isoquinolines; Nausea; Osteosarcoma; Palonosetron; Quinuclidines; Vomiting

2022

Other Studies

1 other study(ies) available for quinuclidines and Osteosarcoma

ArticleYear
PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis.
    Oncogene, 2005, May-12, Volume: 24, Issue:21

    Topics: Adenocarcinoma; Animals; Apoptosis; Aza Compounds; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Interactions; Drug Resistance, Neoplasm; Genes, p53; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Osteosarcoma; Quinuclidines; Transplantation, Heterologous; Tumor Cells, Cultured

2005